Advances in external beam radiotherapy
|
|
- Jessica Booker
- 5 years ago
- Views:
Transcription
1 International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada The Institute of Cancer Research & the Royal Marsden Hospital London & Sutton Versailles, 2 December 2009 Versailles, France December 2 4, 2009
2 Particle RT IGRT IMRT SRT CRT RT DXT New radiotherapy technology
3 Advances in technology Radiotherapy Imaging Systemic therapy Surgery Biomarkers etc Advances in oncology
4 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT (intensity modulated radiotherapy) Protons, Heavy ions Image guided radiotherapy 4D radiotherapy External beam radiotherapy technology
5 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT Protons, Heavy ions Image guided radiotherapy 4D radiotherapy multi-leaf collimator External beam radiotherapy technology
6 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT (intensity modulated radiotherapy) Protons, Heavy ions Image guided radiotherapy 4D radiotherapy multi-leaf collimator altering the beam intensity External beam radiotherapy technology
7 Clinical application of IMRT avoidance of critical structures target dose inhomogeneity concomitant boost within target boost Intensity Modulated Radiotherapy (IMRT)
8 Clinical application of IMRT avoidance of critical structures target dose inhomogeneity concomitant boost within target boost examples: spinal cord avoidance parotid sparing Intensity Modulated Radiotherapy (IMRT)
9 Clinical application of IMRT avoidance of critical structures target dose inhomogeneity concomitant boost within target boost Intensity Modulated Radiotherapy (IMRT)
10 Clinical application of IMRT requiring proof of benefit avoidance of critical structures target dose inhomogeneity concomitant boost within target boost Intensity Modulated Radiotherapy (IMRT)
11 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT Protons, Heavy ions Image guided radiotherapy 4D radiotherapy IMRT Protons External beam radiotherapy technology
12 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT Protons, Heavy ions Image guided radiotherapy 4D radiotherapy External beam radiotherapy technology cone beam CT RT room scanner
13 Modern technology of radiotherapy delivery Conformal radiotherapy IMRT Protons, Heavy ions Image guided radiotherapy 4D radiotherapy External beam radiotherapy technology
14 Changes over a course of radiotherapy - adaptive RT 4D radiotherapy
15 Radiotherapy to a moving target 4D radiotherapy
16 Radiotherapy to a moving target - gating 4D radiotherapy for non-small cell lung cancer
17 Radiotherapy to a moving target - tracking 4D radiotherapy for non-small cell lung cancer
18 Radiotherapy to a moving target tracking tracking with MLC 4D radiotherapy for non-small cell lung cancer
19 Technology Radiotherapy Imaging Systemic therapy Surgery Biomarkers etc Advances in oncology
20 Modern imaging CT MRI Functional Imaging Advances in imaging
21 Modern imaging CT MRI Functional Imaging Advances in imaging
22 Particle RT IGRT IMRT SRT CRT RT DXT New radiotherapy technology
23 Introduction into clinical practice benefits radiotherapy process clinical benefit New radiotherapy technology
24 Introduction into clinical practice requirements: technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
25 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
26 Robotic arm mounted linac (Cyberknife) Modern technology of radiotherapy delivery
27 Comparison of techniques of high precision localised RT Cozzi et al 2006
28 Planning Target Volume (PTV) dose distribution 100 ideal % volume IMRT cyberknife helical tomotherapy (HT) dose (%) Comparison of techniques of high precision localised RT Cozzi et al 2006
29 Normal CNS dose distribution (organs at risk) Comparison of techniques of high precision localised RT Cozzi et al 2006
30 Proton therapy
31 Bragg peak protons Depth dose distribution of photons and protons
32 protons modulated protons Depth dose distribution of photons and protons
33 spread out Bragg peak Depth dose distribution of photons and protons
34 spread out Bragg peak multiple photon (Xray) beams Depth dose distribution of photons and protons
35 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
36 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
37 IMRT Prostate radiotherapy
38 introducing protons IMRT IM protons (IMPT) conformal protons Trofimov et al IJROBP (69), 444, 2007 Prostate radiotherapy
39 1 IMRT Mean SD Rectal sparing IMRT % dose Protons conformal protons IM protons (IMPT) Trofimov et al IJROBP (69), 444, 2007 Prostate radiotherapy
40 1 IMRT Mean SD Bladder sparing IMRT % dose IM protons (IMPT) Protons conformal protons Trofimov et al IJROBP (69), 444, 2007 Prostate radiotherapy
41 Introduction into clinical practice protons technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
42 Clinical evidence for efficacy of protons Tumour control Tumour % 5yr local control best conventional protons* treatment chordoma chondrosarcoma * weighted mean of published studies Brada et al 2007 JCO, 25 (8), Protons in chordoma and chondrosarcoma
43 Clinical evidence for efficacy of protons compared to best conventional treatment Tumour site tumour control survival toxicity Head and neck tumours Prostate cancer Ocular tumours Gastrointestinal cancer Lung cancer CNS tumours Sarcomas Paediatric tumours Protons in other tumours
44 Clinical evidence for efficacy of protons compared to best conventional treatment Tumour site tumour control survival toxicity Head and neck tumours Prostate cancer Ocular tumours Gastrointestinal cancer Lung cancer CNS tumours Sarcomas Paediatric tumours Protons in other tumours
45 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
46 Conventional design Phase I to evaluate Phase II Phase III model of drug testing Evidence based medicine
47 Conventional design to evaluate Phase I clinical pharmacology & toxicity Phase II Phase III model of drug testing Evidence based medicine
48 Conventional design to evaluate Phase I feasibility & toxicity Phase II Phase III model of drug testing Evidence based medicine
49 Conventional design to evaluate Phase I feasibility & toxicity Phase II initial investigation of activity no information on comparative efficacy Phase III model of drug testing Evidence based medicine
50 Problems of Phase II studies study design (prospective/retrospective; statistics) patient selection (performance status, disease status etc) new staging & other treatments comparative control group endpoints and methods of assessment.. Evidence based medicine
51 Conventional design to evaluate Phase I clinical pharmacology & toxicity Phase II initial investigation of activity Phase III comparative efficacy model of drug testing Evidence based medicine
52 Introduction of protons into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
53 Radiotherapy in non-small cell lung cancer implementation of novel techniques assumes a dose response relationship Evaluating new radiotherapy technology
54 Summary of published phase II studies (1201 patients, 8 publications) 2 year local progression free survival 1 Progression-free survival [2 yr] Martel model Fenwick model Clinical data BED [Gy] Dose response in non-small cell lung cancer (NSCLC) Ramos, Partridge et al 2009 (unpublished)
55 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
56 Radiotherapy to a moving lung tumour Evaluating new radiotherapy technology in NSCLC
57 Radiotherapy to a moving target respiratory volume BEAM ON time Conventional radiotherapy for non-small cell lung cancer
58 technology intensive real time tracking predictive tracking regular breathing tracking normal unregulated breathing voluntary breath hold imposed breath hold gating gating with free breathing or breath hold sedation anaesthaesia standard fixed delivery conventional treatment patient intensive Solutions to tumour motion in NSCLC RT
59 Radiotherapy to a moving target active breathing control (ABC) 4D radiotherapy for non-small cell lung cancer
60 respiratory volume Radiotherapy to a moving target active breathing control (ABC) BEAM ON time 4D radiotherapy for non-small cell lung cancer
61 Radiotherapy to a moving target active breathing control (ABC) 4D radiotherapy for non-small cell lung cancer
62 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
63 Change in mean lung parameters Mean Lung Dose (MLD) 15 MLD (Gy) % 20% 0 free breathing FB1 free breathing FB2 ABC larger margin smaller margin active breathing control 4D gated radiotherapy with ABC for NSCLC Panakis et al 2008
64 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit model potential benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
65 Change in tumour control probability (TCP) for iso-ntcp plan (max dose 84Gy) 0.5 TCP at 30 months original plan dose escalated plan (25 patients) Partridge et al D gated radiotherapy with ABC for NSCLC (NTCP normal tissue complication probability)
66 Comparison of techniques Volumetric intensity modulated arc therapy (VMAT) Brock et al 2008
67 Volumetric intensity modulated arc therapy (VMAT)
68 Stereotactic body radiotherapy (SBRT)
69 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
70 Systematic review of published literature (15 studies, 880 patients) at 2 years local progression free survival 89% survival 65% Brock et al Clin Oncol, 20, , 2008 SBRT stereotactic body radiotherapy High dose RT for localised NSCLC (SBRT)
71 Summary of published phase II studies (including SBRT) 2 year local progression free survival 1 2 year local progression free survival Disease-free survival [2 yr] early stage disease advanced stage disease Fenwick model (solid curve) BED [Gy] conventional fractionation hypofractionated SBRT Dose response in non-small cell lung cancer (NSCLC) Partridge, Ramos et al 2009 (unpublished)
72 Introduction into clinical practice technical benefit in clinical setting representative series of patients clinically relevant endpoint clinical benefit surrogate endpoint (tumour control and toxicity) survival and quality of life Evaluating new radiotherapy technology
73 Risks from introduction into clinical practice system problems and complexity system errors demands on under resourced service individual patient risks reliance on image interpretation clinical expertise vs technical prowess commercial interests & direct to patient marketing Evaluating new radiotherapy technology
74 Conventional design to evaluate Phase I clinical pharmacology & toxicity Phase II initial investigation of activity Phase III comparative efficacy model of drug testing Evidence based medicine
75 New technology trial Localised NSCLC conventional dose RT novel technology (gating/tracking/imrt/vmat..) Evaluation of new technology of RT delivery in NSCLC
76 New technology trial Localised NSCLC randomise conventional dose RT conventional technology conventional dose RT novel technology (gating/tracking/imrt/vmat..) Evaluation of new technology of RT delivery in NSCLC
77 Combination of dose escalation with new technology Localised NSCLC randomise conventional dose RT conventional technology high dose RT novel technology (gating/tracking/imrt/...) Evaluation of new technology of RT delivery in NSCLC
78 Introduction into clinical practice benefits radiotherapy process clinical benefit New radiotherapy technology
79 International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Academic Radiotherapy Unit, Joint Department of Physics, Neuro-oncology Unit Lung Unit, Radiotherapy Department Michael Brada Work supported by: NHS Executive Cancer Research UK Neuro-oncology Research Fund Versailles, France December 2 4, 2009
Overview of Advanced Techniques in Radiation Therapy
Overview of Advanced Techniques in Radiation Therapy Jacob (Jake) Van Dyk Manager, Physics & Engineering, LRCP Professor, UWO University of Western Ontario Acknowledgements Glenn Bauman Jerry Battista
More informationSBRT in early stage NSCLC
SBRT in early stage NSCLC Optimal technique and tumor dose Frank Zimmermann Clinic of Radiotherapy and Radiation Oncology University Hospital Basel Petersgraben 4 CH 4031 Basel radioonkologiebasel.ch Techniques
More informationResults of Stereotactic radiotherapy for Stage I and II NSCLC Is There a Need for Image Guidance?
Results of Stereotactic radiotherapy for Stage I and II NSCLC Is There a Need for Image Guidance? Frank Zimmermann Institute of Radiation Oncolgy University Clinic Basel Petersgraben 4 CH 4031 Basel radioonkologiebasel.ch
More informationStereotactic radiotherapy
Stereotactic radiotherapy Influence of patient positioning and fixation on treatment planning - clinical results Frank Zimmermann Institut für Radioonkologie Universitätsspital Basel Petersgraben 4 CH
More informationThe role of Radiation Oncologist: Hi-tech treatments for liver metastases
The role of Radiation Oncologist: Hi-tech treatments for liver metastases Icro Meattini, MD Radiotherapy-Oncology Unit AOU Careggi Hospital Florence University, Italy Liver Metastases - Background The
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationIntensity Modulated RadioTherapy
Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June
More informationSarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington
Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation
More informationClinical Protontherapy Head and Neck cancer
Clinical Protontherapy Head and Neck cancer Coen Rasch Department of Radiation Oncology Academic Medical Center Amsterdam No disclosures 1 Introduction Proton vsphotonin the literature Model basedindicationprotocol
More informationCURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT
CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT Purpose The purpose of this curriculum outline is to provide a framework for multidisciplinary training for radiation oncologists, medical
More informationNew Radiation Treatment Modalities in the Treatment of Lung Cancer
New Radiation Treatment Modalities in the Treatment of Lung Cancer David Perry, M.D. Chief, Radiation Oncology Medical Director, CyberKnife Radiosurgery Center Medstar Franklin Square Medical Center Definitions
More informationFROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
More informationADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER
ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER Bro. Dr. Collie Miller IARC/WHO Based on trends in the incidence of cancer, the International Agency for Research on Cancer (IARC) and WHO
More informationLinac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR
Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,
More informationChanging Paradigms in Radiotherapy
Changing Paradigms in Radiotherapy Marco van Vulpen, MD, PhD Mouldroomdag-2015 Towards the elimination of invasion 1 NIH opinion on the future of oncology Twenty-five years from now,i hope that we won
More informationTreatment Planning for Lung. Kristi Hendrickson, PhD, DABR University of Washington Dept. of Radiation Oncology
Treatment Planning for Lung Kristi Hendrickson, PhD, DABR University of Washington Dept. of Radiation Oncology Outline of Presentation Dosimetric planning strategies for SBRT lung Delivery techniques Examples
More informationIMAT: intensity-modulated arc therapy
: intensity-modulated arc therapy M. Iori S. Maria Nuova Hospital, Medical Physics Department Reggio Emilia, Italy 1 Topics of the talk Rotational IMRT techniques: modalities & dedicated inverse-planning
More informationWhere are we with radiotherapy for biliary tract cancers?
Where are we with radiotherapy for biliary tract cancers? Professor Maria A. Hawkins Associate Professor in Clinical Oncology MRC Group Leader/Honorary Consultant Clinical Oncologist CRUK MRC Oxford Institute
More informationRob Glynne-Jones Mount Vernon Cancer Centre
ESMO Preceptorship Programme Colorectal Cancer Barcelona October 2017 Interventional radiology and stereotactic radiotherapy Rob Glynne-Jones Mount Vernon Cancer Centre My Disclosures: last 5 years Speaker:
More informationRadiotherapy What are our options and what is on the horizon. Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology
Radiotherapy What are our options and what is on the horizon Dr Kevin So Specialist Radiation Oncologist Epworth Radiation Oncology Outline Advances in radiotherapy technique Oligo - disease Advancements
More informationI. Equipments for external beam radiotherapy
I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),
More informationTranslational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen
Translational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen Tumor hypoxia: perfusion and diffusion limited oxygenation Hypoxia acute chronic 100 100
More informationRadiation treatment planning in lung cancer
Radiation treatment planning in lung cancer Georg Dietmar 1,2 1 Div. Medical Rad. Phys., Dept. of Radiation Oncology / Medical Univ. Vienna & AKH Wien 2 Christian Doppler Laboratory for Medical Radiation
More informationPotential conflicts-of-interest. Respiratory Gated and Four-Dimensional Tumor Tracking Radiotherapy. Educational objectives. Overview.
Respiratory Gated and Four-Dimensional Tumor Tracking Radiotherapy Potential conflicts-of-interest I am PI of a sponsored research agreement between Stanford University and Varian Medical Systems P Keall
More informationState of the Art Radiotherapy for Pediatric Tumors. Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center
State of the Art Radiotherapy for Pediatric Tumors Suzanne L. Wolden, MD Memorial Sloan-Kettering Cancer Center Introduction Progress and success in pediatric oncology Examples of low-tech and high-tech
More informationHALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy
The Physical and Biological Basis of By 1899 X rays were being used for cancer therapy David J. Brenner, PhD, DSc Center for Radiological Research Department of Radiation Oncology Columbia University Medical
More informationCredentialing for the Use of IGRT in Clinical Trials
Credentialing for the Use of IGRT in Clinical Trials James M. Galvin, DSc Thomas Jefferson University Hospital Jefferson Medical College Philadelphia, PA and The Radiation Therapy Oncology Group RADIATION
More informationProton- Radiotherapy:
Proton- Radiotherapy: Future of Medical Indications and Treatment Concepts Eugen B. Hug and Ralf A. Schneider HUG 11/07 The emerging role of Proton Radiotherapy in the framework of modern Photon-RT 2000
More informationAn introduction to different types of radiotherapy
An introduction to different types of radiotherapy Radiotherapy can cure cancer. It is delivered to around half of cancer patients and is a vital part of curative treatment in around 40% of patients 1.
More informationQuestions may be submitted anytime during the presentation.
Understanding Radiation Therapy and its Role in Treating Patients with Pancreatic Cancer Presented by Pancreatic Cancer Action Network www.pancan.org August 18, 2014 If you experience technical difficulty
More informationRecent Advances in Breast Radiotherapy
Recent Advances in Breast Radiotherapy Dr Anna Kirby Consultant Clinical Oncologist 2 The Royal Marsden Overview: Key innovations 1. 2D to 3D planning 2. Hypofractionation 3. Intensity modulated radiotherapy
More information4D Radiotherapy in early ca Lung. Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla
4D Radiotherapy in early ca Lung Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla Presentation focus on ---- Limitation of Conventional RT Why Interest in early lung cancer
More informationFuture of Radiation Therapy
Future of Radiation Therapy JP Morgan Healthcare Conference January 12, 2016 Deepak Khuntia, MD, VP of Medical Affairs Patrick Kupelian, MD, VP of Clinical Affairs Cancer as a cause of death CANCER TREATMENT
More informationClinical experience with TomoDirect System Tangential Mode
Breast Cancer Clinical experience with TomoDirect System Tangential Mode European Institute of Oncology Milan, Italy Disclosure & Disclaimer An honorarium is provided by Accuray for this presentation The
More informationENDPOINTS IN ONCOLOGY- HOW LONG WILL A CANCER PATIENT SURVIVE? DR GUNJAN BAIJAL CONSULTANT RADIATION ONCOLOGY MANIPAL GOA
ENDPOINTS IN ONCOLOGY- HOW LONG WILL A CANCER PATIENT SURVIVE? DR GUNJAN BAIJAL CONSULTANT RADIATION ONCOLOGY MANIPAL GOA Why so much of cancer today? Times have changed HISTORICAL PERSPECTIVE CANCER as
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationComparing Current Options in Radiation Therapy. Howard M. Sandler, MD Ronald H. Bloom Family Chair in Cancer Therapeutics Cedars-Sinai Medical Center
Comparing Current Options in Radiation Therapy Howard M. Sandler, MD Ronald H. Bloom Family Chair in Cancer Therapeutics Cedars-Sinai Medical Center Time Trends for Radiotherapy (and other treatments)
More informationRadiation Therapy: From Fallacy to Science
27 th Annual Management of Colon and Rectal Diseases 2.23.2019 Radiation Therapy: From Fallacy to Science Hadi Zahra, MD, DABR Radiation Oncologist CHI Health Henry Lynch Cancer Center Assistant Clinical
More informationFuture upcoming technologies and what audit needs to address
Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple
More informationThe Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology
The Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology (specifically, lung cancer) 2/10/18 Jeffrey Kittel, MD Radiation Oncology, Aurora St. Luke s Medical Center Outline The history
More informationClinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate
Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Reference: NHS England B01X09 First published: March 2016 Prepared by NHS England Specialised Services Clinical
More informationDefining Target Volumes and Organs at Risk: a common language
Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce
More informationNEWER RADIATION (3 D -CRT, IMRT, IGRT) TECHNIQUES FOR CERVICAL CANCERS (COMMON PELVIC TUMORS)
NEWER RADIATION (3 D -CRT, IMRT, IGRT) TECHNIQUES FOR CERVICAL CANCERS (COMMON PELVIC TUMORS) Umesh Mahantshetty, DMRT, MD, DNBR Associate Professor, Radiation Oncology Convener: Urology Disease Management
More informationEORTC Member Facility Questionnaire
Page 1 of 9 EORTC Member Facility Questionnaire I. Administrative Data Name of person submitting this questionnaire Email address Function Phone Institution Address City Post code Country EORTC No Enter
More informationImplementing SBRT Protocols: A NRG CIRO Perspective. Ying Xiao, Ph.D. What is NRG Oncology?
Implementing SBRT Protocols: A NRG CIRO Perspective Ying Xiao, Ph.D. What is NRG Oncology? One of five new NCI-supported National Clinical Trials Network (NCTN) groups. NCTN officially started March 1,
More informationRadiotherapy Advances
Radiotherapy Advances Not Radiotherapy Principles IMRT IGRT Image Fusion Planning Introduction IMRT = Intensity Modulated RadioTherapy Restriction: IMRT with photon beams IMRT: Highly conformal technique
More informationMEDICAL MANAGEMENT POLICY
PAGE: 1 of 8 This medical policy is not a guarantee of benefits or coverage, nor should it be deemed as medical advice. In the event of any conflict concerning benefit coverage, the employer/member summary
More informationUNIVERSITY OF WISCONSIN-LA CROSSE Graduate Studies
UNIVERSITY OF WISCONSIN-LA CROSSE Graduate Studies A SINGLE INSTITUTION S EXPERIENCE IN DEVELOPING A PURPOSEFUL AND EFFICIENT OFF-LINE TECHNIQUE FOR ADAPTIVE RADIOTHERAPY IN A CLINICAL ENVIRONMENT A Research
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationRadiation Therapy 2013 The Role of Protons. Bob Gaston, D.O.
Radiation Therapy 2013 The Role of Protons Bob Gaston, D.O. Disclosures Oklahoma ProCure Treatment Center Radiation Medicine Associates Goal of Radiation Therapy Increase the Therapeutic Ratio Therapeutic
More informationDemands and Perspectives of Hadron Therapy
Demands and Perspectives of Hadron Therapy Alexander Lin, M.D. Assistant Professor University of Pennsylvania Direction of Operations Roberts Proton Therapy Center Disclosures Teva Pharmaceuticals: Advisory
More informationProton therapy for prostate cancer
Proton therapy for prostate cancer Shafak Aluwini Radiation oncologist UMCG Protons versus photons Superior beam properties 200 180 Advantage of protons 160 Photons 140 120 100 Spread out Bragg Peak 80
More informationMany vendors are beginning to allow couch motion during radiation delivery.
Dynamic Couch Motion Many vendors are beginning to allow couch motion during radiation delivery. Varian developer mode allows institutions to perform research using these types of treatments. Tomotherapy
More informationGuidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy
Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy VERSION 2.1 April 2015 Table of Contents Abbreviations & Glossary... 3 Executive Summary...
More informationHelical Tomotherapy Experience. TomoTherapy Whole Brain Head & Neck Prostate Lung Summary. HI-ART TomoTherapy System. HI-ART TomoTherapy System
The Challenges Associated with Differential Dose Delivery using IMRT Chester Ramsey, Ph.D. Director of Medical Physics Thompson Cancer Center Knoxville, Tennessee, U.S.A Collaborators Chester Ramsey, Ph.D.
More informationClinical Precision for Best Cancer Care. Dee Mathieson Senior Vice President Oncology Business Line Management
Clinical Precision for Best Cancer Care Dee Mathieson Senior Vice President Oncology Business Line Management Optimizing clinical results Key drivers in modern Radiation Therapy Clinical precision Continuous
More informationRadiation Treatment Techniques: Where to find rooms for improvement?
Radiation Treatment Techniques: Where to find rooms for improvement? Cedric Yu, D.Sc. Carl M. Mansfield, M.D. Professor University of Maryland School of Medicine Founder and CEO, Xcision Medical Systems,
More informationOverview of Clinical and Research Activities at Georgetown University Hospital
Overview of Clinical and Research Activities at Georgetown University Hospital Dalong Pang, Ph.D. Department of Radiation Medicine Georgetown University Hospital Clinical Operation Two Varian linear accelerators
More informationEconomic Implications of Advancements in Radiation Technology. Dramatic Growth of RT Capacity in the US
Economic Implications of Advancements in Radiation Technology Sponsored by: OTN Anthony M. Berson, M.D. Radiation Oncology, St. Vincent s Comprehensive Cancer Center Richard Emery Vice President, Aptium
More information8/2/2012. Transitioning from 3D IMRT to 4D IMRT and the Role of Image Guidance. Part II: Thoracic. Peter Balter, Ph.D.
8/2/2012 Transitioning from 3D IMRT to 4D IMRT and the Role of Image Guidance Part II: Thoracic Peter Balter, Ph.D. Disclosure Dr. Balter is Physics PI on a trial comparing Cyberknife based SBRT with surgery,
More informationTreatment Planning (Protons vs. Photons)
Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield
More informationInnovation in radiotherapy: How to prove its value for money?
Innovation in radiotherapy: How to prove its value for money? Yolande Lievens, MD, PhD Radiation Oncology Ghent University Hospital & Ghent University, Belgium Co-Chair ESTRO-HERO project ESTRO President
More informationMotion gating and tracking techniques: overview and recent developments
Motion gating and tracking techniques: overview and recent developments Gig S Mageras, PhD, FAAPM Department of Medical Physics Memorial Sloan Kettering Cancer Center, New York MSK/gsm 15-Jun-2018 1 Disclosure
More informationIGRT Solution for the Living Patient and the Dynamic Treatment Problem
IGRT Solution for the Living Patient and the Dynamic Treatment Problem Lei Dong, Ph.D. Associate Professor Dept. of Radiation Physics University of Texas M. D. Anderson Cancer Center Houston, Texas Learning
More informationProtonTherapy: A ballistic that will benefit patients? Pr. Xavier Geets MIRO Lab, IREC UCL Radiotherapy Dept. CUSL, Belgium
ProtonTherapy: A ballistic that will benefit patients? Pr. Xavier Geets MIRO Lab, IREC UCL Radiotherapy Dept. CUSL, Belgium Proton Therapy, a swissknife The balistic advantage of protons P PHOTON THERAPY
More informationProstate Cancer Appraisal Addendum: Stereotactic Body Radiation Therapy (SBRT)
Prostate Cancer Appraisal Addendum: Stereotactic Body Radiation Therapy (SBRT) The Institute for Clinical and Economic Review (ICER) has published appraisals on multiple management options for clinically-localized,
More informationImplementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Implementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Implementation of radiosurgery and SBRT requires a fundamentally sound approach Errors don t blur out
More informationInnovazioni tecnologiche in Radioterapia" Sergio Fersino Radioterapia Oncologica
Innovazioni tecnologiche in Radioterapia" Sergio Fersino Radioterapia Oncologica 2014 HYPOFRACTIONATION & PROSTATE CANCER HYPOFRACTIONATION & PROSTATE CANCER: TECHNOLOGY: HIGH CONFORMAL DOSE & IMAGING
More informationTomoTherapy. Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA. May 2016
TomoTherapy Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA May 2016 TomoTherapy The Facts Greek Tomo = slice Advanced form of IMRT 3D computerised tomography (CT) imaging immediately prior
More informationThe TomoTherapy System as a Tool of Differentiation in Quality and Marketability
The TomoTherapy System as a Tool of Differentiation in Quality and Marketability John J. Kresl, MD, PhD, FACRO, FACR Medical Director Phoenix CyberKnife & Radiation Oncology Center Managing Partner Phoenix,
More informationOverview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS
IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS Heng Li, PhD Assistant Professor, Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX, 773
More informationVerification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film
Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film E.B.Rajmohan¹, Pratik Kumar¹, Bhudatt Paliwal,² David Westerly², N.Gopishankar³, R.K.Bisht³, D.Tewatia²,
More informationClinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience
Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery
More informationCharged-Particle (Proton or Helium Ion) Radiation Therapy. Original Policy Date
MP 8.01.08 Charged-Particle (Proton or Helium Ion) Radiation Therapy Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationExternal Beam Radiotherapy for Prostate Cancer
External Beam Radiotherapy for Prostate Cancer Chomporn Sitathanee, Radiation Oncology Unit Ramathibodi Hospital, Mahidol University Roles of RT in prostate cancer Definitive RT; intact prostate Post radical
More informationJean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division
IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy: Jean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division Should Choices be Based on Dosimetric and
More informationAsynchronization. (aka MLC interplay effect with tumor motion)
Asynchronization (aka MLC interplay effect with tumor motion) Asynchronization is what happens when two moving parts do not align as planned. Like when my mother wants a photograph of her five young grandchildren.
More informationIntensity-Modulated and Image- Guided Radiation Treatment. Outline. Conformal Radiation Treatment
Intensity-Modulated and Image- Guided Radiation Treatment J. Daniel Bourland, PhD Professor Departments of Radiation Oncology, Physics, and Biomedical Engineering Wake Forest University School of Medicine
More informationTherapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR
Therapeutic Medical Physics Stephen J. Amadon Jr., Ph.D., DABR Outline 1. Why physicists are needed in medicine 2. Branches of medical physics 3. Physics in Radiation Oncology 4. Treatment types and Treatment
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationThierry M. Muanza, MSc, MD, FRCPC,, McGill University Segal Cancer Centre, Jewish General Hospital Montreal, QC, Canada
Thierry M. Muanza, MSc, MD, FRCPC,, McGill University Segal Cancer Centre, Jewish General Hospital Montreal, QC, Canada Déclarations Aucun conflit d intérêt Objectifs d apprentissage Évolution de la radiothérapie
More informationImage Guided Stereotactic Radiotherapy of the Lung
Image Guided Stereotactic Radiotherapy of the Lung Jamie Marie Harris, MS DABR Avera McKennan Radiation Oncology September 25, 2015 Stereotactic Body Radiotherapy - Clinical Dose/Fractionation - Normal
More informationMRI Applications in Radiation Oncology:
MRI Applications in Radiation Oncology: Physician s Perspective Jeff Olsen, MD Department of Radiation Oncology Washington University, St. Louis, MO Disclosures Washington University has research and service
More informationProton- Radiotherapy: Overview of Clinical Indications
Proton- Radiotherapy: Overview of Clinical Indications Eugen B. Hug (with emphasis on indications treated at PSI For comprehensive clinical reviews: ESTRO or PTCOG seminars) HUG 11/07 Complication Free
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationCharged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions Policy Number: 8.01.10 Last Review: 11/2017 Origination: 11/2006 Next Review: 11/2018 Policy Blue Cross and Blue Shield of
More informationClinical Implications Of Dose Summation And Adaptation
Clinical Implications Of Dose Summation And Adaptation Patrick Kupelian, M.D. Professor and Vice Chair University of California Los Angeles Department of Radiation Oncology pkupelian@mednet.ucla.edu August
More informationNational Institute for Health and Clinical Excellence. Health Technology Appraisal. IIntensity modulated radiotherapy for prostate cancer
Summary form Comment 1: the draft remit National Institute for Health and Clinical Excellence Health Technology Appraisal IIntensity modulated radiotherapy for prostate cancer Response to consultee and
More informationRadiotherapy physics & Equipments
Radiotherapy physics & Equipments RAD 481 Lecture s Title: An Overview of Radiation Therapy for Health Care Professionals Dr. Mohammed Emam Vision :IMC aspires to be a leader in applied medical sciences,
More informationParticle (proton) Therapy Randomized trials vs. Prospective registry. Andrew K. Lee, MD, MPH Associate Professor Department of Radiation Oncology
Particle (proton) Therapy Randomized trials vs. Prospective registry Andrew K. Lee, MD, MPH Associate Professor Department of Radiation Oncology Should we do randomized trials? Are randomized trials needed
More informationPACE Study. Hypofractionation 17/12/2014. Traditional Model of Fractionation 200 Response. What s the fraction sensitivity of prostate cancer?
0 0 17/12/2014 2 Outline of today s talk PACE Study Background rationale for PACE? Dr Nicholas van As A bit about technology. What is PACE? How can I get involved? London: 1 December 2014 250 Hypofractionation
More information8/3/2016. Outline. Site Specific IGRT Considerations for Clinical Imaging Protocols. Krishni Wijesooriya, PhD University of Virginia
Site Specific IGRT Considerations for Clinical Imaging Protocols Krishni Wijesooriya, PhD University of Virginia Outline Image registration accuracies for different modalities What imaging modality best
More informationParticle Radiation Therapy: CurrentStatus Indications -Results
Particle Radiation Therapy: CurrentStatus Indications -Results Eugen B. Hug Center for Proton Therapy Paul Scherrer Institute and University of Zürich Switzerland Particle Radiation Therapy: Selection
More informationPrinciples of radiotherapy and radiochemotherapy. Polgár Cs. 1,2 National Institute of Oncology 1, Chair of Oncology, Semmelweis University 2
Principles of radiotherapy and radiochemotherapy of malignant tumours Polgár Cs. 1,2 National Institute of Oncology 1, Chair of Oncology, Semmelweis University 2 Multidisciplinary treatment of malignant
More informationWhich Planning CT Should be Used for Lung SBRT? Ping Xia, Ph.D. Head of Medical Physics in Radiation Oncology Cleveland Clinic
Which Planning CT Should be Used for Lung SBRT? Ping Xia, Ph.D. Head of Medical Physics in Radiation Oncology Cleveland Clinic Outline Image quality and image dose Free breathing CT, 4DCT, and synthetic
More informationOriginal Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem
Original Article Treatment Planning Evaluation of Sliding Window and Multiple Static Segments Technique in Intensity Modulated Radiotherapy for Different Beam Directions Teyyiba Kanwal, Muhammad Khalid,
More informationCombined modality treatment for N2 disease
Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical
More information